The total return over the past 12 months is -74.48% vs. +16.94% for the S&P 500. So far it's up -29.06% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (74.48%) | (79.23%) | N/A | N/A | N/A | N/A |
| Total Return CAGR | (74.48%) | (79.23%) | N/A | N/A | N/A | N/A |
| Revenue CAGR | +68.02% | +87.22% | (14.35%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
60 Degrees Pharmaceuticals, Inc. (SXTP)
| Year | Start price | End price | SXTP Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $2.03 | $1.44 | (29.06%) | +14.51% | (43.57%) |
| 2025 | $25.80 | $2.03 | (92.13%) | +17.72% | (109.85%) |
| 2024 | $244.80 | $25.80 | (89.46%) | +24.89% | (114.35%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
